Follow our Journeys
Sharing success stories internal to Duke Capital Partners and external to our portfolio companies.
Duke Angel Network is now Duke Capital Partners
08th Nov 2022
Duke University’s early-stage venture investment arm, Duke Angel Network, is now Duke Capital Partners. Duke Capital Partners provides capital and expertise to help Duke startups, and features one of Duke’s most innovative experiential learning opportunities for students.
Associate Spotlight: Cameron Irwin
Before his time at Duke, DAN’s Lead Law Associate Cameron Irwin handled many roles at a young startup. That experience sparked a passion for working with emerging companies that Cam carries with him today.
Associates Class of 2022 announced
The DAN Associate Program brings together some of the University’s brightest minds from graduate schools across Duke University — including the Duke University School of Medicine, Duke University - The Fuqua School of Business, Duke…
Sparta Biomedical spotlighted by World Economic Forum
Sparta Biomedical was recently spotlighted by the World Economic Forum on their Instagram. Read more to see the video and learn more about Sparta Biomedical.
Read More about Sparta Biomedical spotlighted by World Economic Forum
Duke University researchers have developed a gel-based cartilage substitute
Implants made of the material are currently being developed by Duke Capital Partners portfolio company Sparta Biomedical and tested in sheep. Researchers are gearing up to begin clinical trials in humans next year.
Read More about Duke University researchers have developed a gel-based cartilage substitute
Duke Capital Partners portfolio company, xilis, has closed a $19M+ extension to its Series A financing
xilis is a pioneering biotech company developing its MicroOrganoSphereTM (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and development.
InnAVasc Medical, Inc., a Duke Capital Partners portfolio company, has been acquired by W. L. Gore & Associates.
InnAVasc, a Duke Capital Partners portfolio company, has been acquired by W. L. Gore & Associates. Gore will add InnAVasc's dialysis graft tech to its medical advanced materials unit.